Janssen-Cilag Pharma GmbH
1 clinical trials · Sponsor
◉ Watch Janssen-Cilag Pharma GmbH
| Record | Firm | Date |
|---|---|---|
| A Study of Guselkumab in Participants With Crohn's Disease and Ulcerative Colitis (NCT07606339) | Janssen-Cilag Pharma GmbH | 2026-06-10 |
Track Janssen-Cilag Pharma GmbH automatically
Every clearance here is in the API, with alerts when new ones post.